Bringing Cure...Building Hope...
Home | Blog | FAQs

EVRYSDI (risdiplam) for oral solution

EVRYSDI (risdiplam) Can be imported and made available on "patient name basis" treatment in India and other countries
Generic Name: Risdiplam. Brand Name: Evrysdi.
EVRYSDI (risdiplam) for oral solution
is a prescription medicine used for the treatment of patients with spinal muscular atrophy (SMA).

Therapeutic indications and Usage Evrysdi is indicated for the treatment of 5q spinal muscular atrophy (SMA) in patients 2 months of age and older, with a clinical diagnosis of SMA Type 1, Type 2 or Type 3 or with one to four SMN2 copies.
Source Details: Patient Information

PATIENT NAME BASIS Treatment EVRYSDI (risdiplam) for oral solution is a prescription medicine, which can be imported and made available on "patient name basis" treatment in India and other countries.

Health Professional In India If you have any question, please email IPN Support Team or Call Indian Pharma Network for EVRYSDI (risdiplam) for oral solution price list or cost in India. on
Mr. Tarun:- +91 9891 296 838
Mr. Neeraj:- +91 9811 747 774

Indian Pharma Network, New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified professionals of pharmaceutical Industry. Specialized in Oncology Pharmacy. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur

EVRYSDI (risdiplam)injection

Facts of EVRYSDI (risdiplam) for oral solution

EVRYSDI is a survival of motor neuron 2 (SMN2) splicing modifier indicated for the treatment of spinal muscular atrophy (SMA) in patients 2 months of age and older The U.S. Food and Drug Administration today approved Evrysdi (risdiplam) to treat patients two months of age and older with spinal muscular atrophy (SMA), a rare and often fatal genetic disease affecting muscle strength and movement. This is the second drug and the first oral drug approved to treat this disease.

“Evrysdi is the first drug for this disease that can be taken orally, providing an important treatment option for patients with SMA, following the approval of the first treatment for this devastating disease less than four years ago,” said Billy Dunn, M.D., director of the Office of Neuroscience in the FDA’s Center for Drug Evaluation and Research.
Source content : www.accessdata.fda.gov

IPN is a facilitator under Patient Name Basis Treatment. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of EVRYSDI (risdiplam) injection in India, Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the EVRYSDI (risdiplam) injection medicine cost price in India.

The order for EVRYSDI (risdiplam) injection will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Risdiplam, sold under the brand name Evrysdi, is a medication used to treat spinal muscular atrophy (SMA) and the first oral medication approved to treat this disease. Risdiplam is a survival of motor neuron 2-directed RNA splicing modifier.

Risdiplam was approved by the US Food and Drug Administration (FDA) in August 2020, for the treatment of adults and children two months of age or older. Developed in association with PTC Therapeutics and the SMA Foundation, it is marketed in the US by Genentech, a subsidiary of Roche.

EVRYSDI (risdiplam) for oral solution, for subcutaneous use.
Initial U.S. Approval: 2020

For Oral Solution: 60 mg of risdiplam as a powder for constitution to provide 0.75 mg/mL solution

For EVRYSDI (risdiplam)Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

Evrysdi approved in Japan for the treatment of spinal muscular atrophy For More Details

FDA Approves Oral Treatment for Spinal Muscular Atrophy For More Details

Step 1. You send a request for your medicine online:- Submit a request for a specific medicine, or a general request, and your Patient Support Manager will contact you within 24 hours. They will be there to support and guide you in anyway possible to help you get the medicine you need.

Step 2. We verify your prescription and medical details:- Since we help patients access medicines not available in their home country, our first step is to check that the medicine you need is not currently available in your home country. Next we will also verify that you have a prescription from a doctor in your home country for the medicine you need.

Step 3. We source your medicine:- Once we have verified your prescription and medical details, our expert sourcing team will work with our global network of suppliers to find you the best price. Once we have found you the lowest possible cost for your medicine, we will present you with a final offer for your approval.

Step 4. We deliver your medicine:- After you have accepted our offer, our experienced logistics team will arrange all the shipping and transportation of your medicine.

Doctor’s Prescription –
We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.

Patient’s Medical history –
We would require all test reports and medical reports of the patient for last 3 months.

Patient’s Identity card –
We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

EVRYSDI (risdiplam) exporter and suppliers in India Can I get anti-cancer medicines even if I am not based in India?
Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. Indian Pharma Network, New Delhi can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find out -
EVRYSDI (risdiplam) price in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
EVRYSDI (risdiplam) price in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
EVRYSDI (risdiplam) price in North America – Mexico.
EVRYSDI (risdiplam) price in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
EVRYSDI (risdiplam) price in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
EVRYSDI (risdiplam) price in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
EVRYSDI (risdiplam) price in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
EVRYSDI (risdiplam) price in Australia and New Zealand.

For this medication, standard shipping applies. This means that a consistent room temperature of 15 to 25°C is maintained during transit.

Your order will be shipped to you by our partner couriers, such as DHL, UPS and specialised cold chain couriers. If you would like your order to be shipped by a specific courier, please inform us when you place the order. Our standard delivery time varies from 5 to 10 working days. The shipping cost depends on the medicine and the destination country. After making an enquiry, you will receive a detailed quote that includes the shipping costs.